Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06557291
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-13
Brief Title:
Relapse-Free Survival With Adjuvant DabrafenibTrametinib Therapy in Patients With BRAF V600-mutated Stage IIIIV Melanoma
Sponsor:
None
Organization:
None
Conditions & Keywords Data
Conditions:
Keywords: